CVR: 42613207
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Berg. The company is owned by HOGDALL HOLDING ApS, WISV Holding ApS and JKimer Holding ApS. In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity amounted to DKK -13,516,567.
Selskabets formål er at udvikle medicinsk hjemmemonitorering af høj kvalitet og digitale terapiløsninger som hjælp til, at patienter med kroniske sygdomme håndterer deres sygdom bedre og forbedrer livskvaliteten.
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
On October 27, 2025, HEI Therapeutics ApS entered liquidation.
As of October 17, 2025, Winnie Edith Svendsen has left the board of directors of HEI Therapeutics ApS.
As of October 17, 2025, Jesper Kimer has left the board of directors of HEI Therapeutics ApS.
As of October 17, 2025, Kenneth Berg is registered as liquidator of HEI Therapeutics ApS.
As of October 17, 2025, Winnie Edith Svendsen has stepped down as director of HEI Therapeutics ApS.
As of October 17, 2025, Dan Taksony Solyom Høgdall has stepped down as director of HEI Therapeutics ApS.
As of October 17, 2025, Jesper Kimer has stepped down as director of HEI Therapeutics ApS.
On October 17, 2025, HEI Therapeutics ApS entered liquidation.
HEI Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK 1,762,455, and the net result was DKK -12,890,414.
HEI Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 3,935,885, and the net result was DKK -381,736.
HEI Therapeutics ApS has published its interim report for the period August 20, 2021 – December 31, 2022.
As of September 21, 2022, Winnie Edith Svendsen has joined the board of directors of HEI Therapeutics ApS.
As of September 21, 2022, Jesper Kimer has joined the board of directors of HEI Therapeutics ApS.
As of September 21, 2022, Winnie Edith Svendsen is registered as director of HEI Therapeutics ApS.
As of September 21, 2022, Dan Taksony Solyom Høgdall is registered as director of HEI Therapeutics ApS.
As of August 20, 2021, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of HEI Therapeutics ApS.
As of August 20, 2021, Jesper Kimer is registered as director of HEI Therapeutics ApS.
As of August 20, 2021, HOGDALL HOLDING ApS is registered as an owner of HEI Therapeutics ApS with an ownership share of 10%.
As of August 20, 2021, WISV Holding ApS is registered as an owner of HEI Therapeutics ApS with an ownership share of 33%.
As of August 20, 2021, JKimer Holding ApS is registered as an owner of HEI Therapeutics ApS with an ownership share of 50%.
HEI Therapeutics ApS was founded on August 20, 2021.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 43506242
CVR 40766383
CVR 42731323
companydata.dk